Blockade of Glucocorticoid Excess at the Tissue Level: Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 as a Therapy for Type 2 Diabetes
- 期刊名称Journal of Medicinal Chemistry
- 作者Fotsch, Christopher; Wang, Minghan
- 卷第51卷
- 期第16期
- 印刷ISSN0022-2623
- 电子ISSN1520-4804
- 文件大小136.42KB
- 发表时间2008-08
- DOI10.1021/jm800369f
- 页码4851-4857
Inhibitors of 11β-HSD1: A Potential Treatment for the Metabolic SyndromeJean Jr., David J.; Wang, Minghan; Fotsch, Christopher · Current Topics in Medicinal Chemistry · 2008
Small-Molecule Compounds that Modulate Lipolysis in Adipose Tissue: Targeting Strategies and Molecular ClassesMinghan Wang; Christopher Fotsch · 2006
Piperazine Oxadiazole Inhibitors of Acetyl-CoA CarboxylaseBourbeau, Matthew P.; Siegmund, Aaron; Allen, John G.; Shu, Hong; Fotsch, Christopher; Bartberger, Michael D.; Kim, Ki-Won; Komorowski, Renee; Graham, Melissa; Busby, James; Wang, Minghan; Meyer, James; Xu, Yang; Salyers, Kevin; Fielden, Mark; Véniant, Murielle M.; Gu, Wei · Journal of Medicinal Chemistry · 2013
Structural Characterization and Pharmacodynamic Effects of an Orally Active 11β-Hydroxysteroid Dehydrogenase Type 1 InhibitorClarence Hale; Murielle Véniant; Zhulun Wang; Michelle Chen; Jocelyn McCormick; Rod Cupples; Dean Hickman; Xiaoshan Min; Athena Sudom; Haoda Xu; Guy Matsumoto; Christopher Fotsch; David J. St. Jean Jr; Minghan Wang · 2008
The discovery of 2-anilinothiazolones as 11β-HSD1 inhibitorsChester Yuan; David J. St. Jean Jr.; Qingyian Liu; Lynn Cai; Aiwen Li; Nianhe Han; George Moniz; Ben Askew; Randall W. Hungate; Lars Johansson; Lars Tedenborg; David Pyring; Meredith Williams; Clarence Hale; Michelle Chen; Rod Cupples; Jiandong Zhang; Steven Jordan; Michael D. Bartberger; Yaxiong Sun; Maurice Emery; Minghan Wang; Christopher Fotsch · 2007
ChemInform Abstract: Blockade of Glucocorticoid Excess at the Tissue Level: Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 as a Therapy for Type 2 DiabetesChristopher Fotsch; Minghan Wang · 2008
Synthesis and Evaluation of the Metabolites of AMG 221, a Clinical Candidate for the Treatment of Type 2 DiabetesLi, Aiwen; Yuan, Chester C.; Chow, David; Chen, Michelle; Emery, Maurice G.; Hale, Clarence; Zhang, Xiping; Subramanian, Raju; St. Jean, David J.; Komorowski, Renee; Véniant, Murielle; Wang, Minghan; Fotsch, Christopher · ACS Medicinal Chemistry Letters · 2011
Antivirals Targeting Influenza A VirusDas, Kalyan · Journal of Medicinal Chemistry · 2012
Chemokine Receptor AntagonistsPease, James; Horuk, Richard · Journal of Medicinal Chemistry · 2012
Thiolesters of orotic acidSargent, Dale R.; Skinner, Charles G. · Journal of Medicinal Chemistry · 1972
Antidiabetic Agents. N <sup>4</sup> -ArylsulfonylsemicarbazidesWright, John B.; Willette, Robert E. · Journal of Medicinal and Pharmaceutical Chemistry · 1962
Nicotinic Acid Receptor AgonistsBoatman, P. Douglas; Richman, Jeremy G.; Semple, Graeme · Journal of Medicinal Chemistry · 2008
Book ReviewsJournal of Medicinal Chemistry · 1985
The benzodiazepine storySternbach, Leo H. · Journal of Medicinal Chemistry · 1979
Anxioselective anxiolyticsWilliams, Michael · Journal of Medicinal Chemistry · 1983